Registry for patients undergoing atrial fibrillation ablation
The Vanderbilt Atrial Fibrillation Ablation Registry
This study is collecting health information and samples from patients getting treatment for atrial fibrillation to see what factors affect how well the treatment works.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Vanderbilt University Medical Center Academic / other |
| Locations | 1 site (Nashville, Tennessee) |
| Trial ID | NCT02404415 on ClinicalTrials.gov |
What this trial studies
The Vanderbilt Atrial Fibrillation Ablation Registry (VAFAR) is a prospective clinical and genetic biorepository that enrolls patients scheduled for atrial fibrillation (AF) ablation. It collects detailed medical histories, imaging data, and biological samples to identify predictors of response to AF ablation. The registry aims to enhance patient selection for the procedure and serves as a resource for research into the mechanisms of AF. Follow-up assessments are conducted at 3, 6, and 12 months post-ablation to monitor arrhythmia recurrence.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who are scheduled for an atrial fibrillation ablation procedure.
Not a fit: Patients who are not scheduled for an atrial fibrillation ablation procedure will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved patient outcomes by identifying which patients are most likely to benefit from AF ablation.
How similar studies have performed: Other studies have shown success with similar registries in improving patient selection and outcomes in atrial fibrillation treatments.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: 1. Age \>18 years 2. Able to give written, informed consent 3. Scheduled for an ablation procedure to treat atrial fibrillation Exclusion criteria: 1. None
Where this trial is running
Nashville, Tennessee
- Vanderbilt University Medical Center — Nashville, Tennessee, United States (Recruiting)
Study contacts
- Principal investigator: Moore B Shoemaker, MD, MSCI — Vanderbilt University
- Study coordinator: Moore B Shoemaker, MD, MSCI
- Phone: 615 322
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.